Skip to search formSkip to main contentSkip to account menu

Polychemotherapy

Known as: Polychemotherapies 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
BACKGROUND Chronic lymphocytic leukaemia (CLL) accounts for 25% of all leukaemias and is the most common lymphoid malignancy in… 
2009
2009
I n contrast with most primary cutaneous B-cell lymphomas, primary cutaneous large B-cell lymphomas, leg type (PCLBCLs-LT) are… 
Review
2007
Review
2007
Aims  In the metastatic stage, malignant melanoma is resistant to systemic treatment and carries a poor prognosis. A critical… 
Highly Cited
2004
Highly Cited
2004
Moderate intensification of conventional multicycle chemotherapy has recently been shown to improve treatment results in… 
Review
2001
Review
2001
Among the novel chemotherapeutic drugs introduced in the 1990s, the taxanes have emerged as the most powerful compounds in breast… 
Highly Cited
1996
Highly Cited
1996
PURPOSE Venous access ports (VAPs) can be used to administer polychemotherapy to patients with malignancies. The purpose of this… 
1986
1986
20 patients with F.I.G.O. stages III ovarian cancer were entered into a randomised trial between January 1980 and March 1984… 
1982
1982
Since in the treatment of advanced breast cancer chemotherapy and the various hormonal manipulations seem recently to have…